Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Avanos Medical (AVNS) Gross Profit (2016 - 2025)

Avanos Medical (AVNS) has disclosed Gross Profit for 13 consecutive years, with $86.0 million as the latest value for Q4 2025.

  • Quarterly Gross Profit fell 12.24% to $86.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $353.9 million through Dec 2025, down 7.19% year-over-year, with the annual reading at $353.9 million for FY2025, 7.19% down from the prior year.
  • Gross Profit hit $86.0 million in Q4 2025 for Avanos Medical, roughly flat from $86.0 million in the prior quarter.
  • In the past five years, Gross Profit ranged from a high of $106.6 million in Q1 2022 to a low of $32.3 million in Q4 2021.
  • Historically, Gross Profit has averaged $91.3 million across 5 years, with a median of $93.8 million in 2024.
  • Biggest five-year swings in Gross Profit: plummeted 62.66% in 2021 and later skyrocketed 218.58% in 2022.
  • Year by year, Gross Profit stood at $32.3 million in 2021, then surged by 218.58% to $102.9 million in 2022, then fell by 7.68% to $95.0 million in 2023, then rose by 3.16% to $98.0 million in 2024, then dropped by 12.24% to $86.0 million in 2025.
  • Business Quant data shows Gross Profit for AVNS at $86.0 million in Q4 2025, $86.0 million in Q3 2025, and $92.1 million in Q2 2025.